tert-butyl 3-[(2-methoxyethyl)amino]propanoate, 95.0%, 2g

5-(4-Bromophenyl)-3-methyl-1H-pyrazole, 95.0%, 1g

4-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine, 98+%, 250mg

Methyl 4-mercaptobenzoate, 97%, 5g

3-IODO-IMIDAZO[1,2-A]PYRIDINE-7-METHANOL, 95.0%, 1g

1-Benzyl-4-(5-chloro-[1,2,4]thiadiazol-3-yl)-piperazine, 95.0%, 1g

5-Bromo-8-methyl-imidazo[1,2-a]pyridine, 95+%, 500mg

4-BROMO-6-INDAZOLECARBOXYLIC ACID METHYL ESTER, 95%, 25g

GC capillary column ROTI®Cap-1 MS, 60 m, 0.25 mm, 0.25 µm, 1 Piece(s)

2-(2H-1,3-benzodioxol-5-yl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine, 95.0%, 1g

(3aR,5R,6S,6aR)-5-(((tert-Butyldiphenylsilyl)oxy)methyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-ol, 95%, 250mg

1-[(oxolan-2-yl)methyl]-1,4-diazepane, 95.0%, 2g

5-Chloro-2-naphthoic acid, 95.0%, 1g